Drug Store News - Luxiq receives marketing OK
April 26, 1999 -- The Food and Drug Adminsitration has granted marketing clearance to Luxiq (betamethasone valerate) Foam, 0.12%, a novel, fast-acting foam formulation...
Business Wire - Stiefel Laboratories Will Enter Into Private Equity Minority Investment Agreement with The Blackstone Group
August 9, 2007 -- Partnering with The Blackstone Group Provides Robust Platform for Continued Growth CORAL GABLES, Fla. -- Stiefel Laboratories, Inc. announced today...
Business Wire - FDA Grants Connetics Marketing Clearance for Luxiq
March 2, 1999 -- PALO ALTO, Calif.--(BW HealthWire)--March 2, 1999--Connetics Corporation (Nasdaq:CNCT) announced today that the Food and Drug Administration (FDA)...
Business Wire - Stiefel Laboratories Receives FDA Approval of Olux-E Foam, 0.05% for Treatment of Psoriasis and Eczema
January 23, 2007 -- -- Company's Second Product in Emollient-Based Foam Delivery Vehicle -- CORAL GABLES, Fla. -- Stiefel Laboratories, Inc., the world's largest...
Business Wire - Connetics Announces Results of Special Stockholders Meeting
December 20, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Journal of Drugs in Dermatology - Verdeso Foam approved for atopic dermatitis
November 1, 2006 -- Connetics Corporation recently announced that Verdeso Foam (desonide 0.05%) has been approved by the FDA for the treatment of mild to moderate atopic...
Business Wire - Connetics Corporation and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
October 23, 2006 -- Strategic Combination to Create World's Premier Dermatology Company Connetics' Stockholders to Receive $17.50 per Share in Cash, Representing a 62%...
Business Wire - FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
September 19, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT): - First approved product formulated in Connetics' emulsion foam (VersaFoam(R)-EF)...
Business Wire - Connetics Expands Commercial and Corporate Development Leadership
August 25, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (NASDAQ:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
Business Wire - Connetics Reports New Option Grants Under Nasdaq Marketplace Rule 4350
August 8, 2006 -- PALO ALTO, Calif. -- Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products,...
